Drug Shortage Report for BUSCOPAN
| Report ID | 257641 |
| Drug Identification Number | 00363839 |
| Brand name | BUSCOPAN |
| Common or Proper name | Nom commun ou nom propre |
| Company Name | SANOFI CONSUMER HEALTH INC |
| Market Status | MARKETED |
| Active Ingredient(s) | HYOSCINE BUTYLBROMIDE |
| Strength(s) | 20MG |
| Dosage form(s) | SOLUTION |
| Route of administration | SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR |
| Packaging size | Taille de l’emballage |
| ATC code | A03BB |
| ATC description | BELLADONNAAND DERIVATIVES, PLAIN |
| Reason for shortage | Requirements related to complying with good manufacturing practices. |
| Anticipated start date | 2020-01-01 |
| Actual start date | |
| Estimated end date | Unknown |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2025-10-31 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2905 PLACE LOUIS-R RENAUD LAVAL, QUEBEC CANADA H7V 0A3 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2025-10-31 | French | Compare |
| v1 | 2025-10-31 | English | Compare |
Showing 1 to 2 of 2